熱門資訊> 正文

Orthofix的肢体保存溶液获得FDA批准和CE标志

2025-03-19 22:13

Orthofix國際(OFIX) 0
stem inc(STEM) 0

Orthofix Medical Inc (NASDAQ:OFIX) said on Wednesday it received U.S. FDA 510((k)) clearance and the European CE Mark for the TrueLok Elevate Transverse Bone Transport System.
TrueLok Elevate offers a limb preservation solution for treating bone and soft tissue deformities, including diabetic foot ulcers and chronic or deep wounds that fail to heal.

More on Orthofix Medical Inc.

Orthofix Medical Inc. (OFIX) Q4 2024 Earnings Call Transcript
Orthofix Medical Inc. 2024 Q4 - Results - Earnings Call Presentation
Orthofix Medical Inc. GAAP EPS of -$0.75 misses by $0.52, revenue of $215.7M beats by $2.98M
Seeking Alpha’s Quant Rating on Orthofix Medical Inc.
Historical earnings data for Orthofix Medical Inc.

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。